Cell cycle regulatory E3 ubiquitin ligases as anticancer targets

Drug Resistance Updates

Volumn 5, Issue 6, 2002, Pages 249-258

  Pray, Todd R ^a   Parlati, Francesco ^a   Huang, Jianing ^a   Wong, Brian R ^a   Payan, Donald G ^a   Bennett, Mark K ^a   Issakani, Sarkiz Daniel ^a   Molineaux, Susan ^a   Demo, Susan D ^a  

^a RIGEL PHARMACEUTICALS INC   (United States)

Author keywords

APC; Drug discovery; Inhibitor; MDM2; SCF

Indexed keywords

ANAPHASE PROMOTING COMPLEX; ANTINEOPLASTIC AGENT; POLYPEPTIDE; POLYUBIQUITIN; PROTEIN MDM2; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN PROTEIN LIGASE;

APOPTOSIS; CANCER; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; DRUG TARGETING; ENZYME REGULATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN STABILITY; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE PROTEINS; ENZYME INHIBITORS; HUMANS; LIGASES; NEOPLASMS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 0036968468     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-7646(02)00121-8     Document Type: Article

References (81)

1. Adams, J., 2002. Proteasome inhibition: a novel approach to cancer therapy. Trends Mol. Med. 8, S49-S54
2. Amir, R.E., Iwai, K., Ciechanover, A., 2002. The NEDD8 pathway is essential for SCF(beta-TrCP)-mediated ubiquitination and processing of the NF-kappa B precursor. J. Biol. Chem. 277, 23253-23259
3. Baer, R., Ludwig, T., 2002. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. Curr. Opin. Genet. Dev. 12, 86-91
4. Berleth, E.S., Kasperek, E.M., Grill, S.P., Braunscheidel, J.A., Graziani, L.A., Pickart, C.M., 1992. Inhibition of ubiquitin-protein ligase (E3) by mono- and bifunctional phenylarsenoxides. Evidence for essential vicinal thiols and a proximal nucleophile. J. Biol. Chem. 267, 16403-16411
5. Blattner, C., Hay, T., Meek, D.W., Lane, D.P., 2002. Hypophosphorylation of Mdm2 augments p53 stability. Mol. Cell Biol. 22, 6170-6182
6. Boyd, S.D., Tsai, K.Y., Jacs, T., 2000. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat. Cell Biol. 2, 563-568
7. Chaturvedi, P., Sudakin, V., Bobiak, M.L., Fisher, P.W., Mattem, M.R., Jablonski, S.A., Hurle, M.R., Zhu, Y., Yen, T.J., Zhou, B.B., 2002. Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity. Cancer Res. 62, 1797-1801
8. Cheng, J.Q., Jiang, X., Fraser, M., Li, M., Dan, H.C., Sun, M., Tsang, B.K., 2002. Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway. Drug Resist. Updates 5, 131-146
9. Clifford, S.C., Maher, E.R., 2001. Von Hippel-Lindau disease: clinical and molecular perspectives. Adv. Cancer Res. 82, 85-105
10. Cook, W.J., Jeffrey, L.C., Sullivan, M.L., Vierstra, R.D., 1992. Three-dimensional structure of a ubiquitin-conjugating enzyme (E2). J. Biol. Chem. 267, 15116-15121
11. Coscoy, L., Sanchez, D.J., Ganem, D., 2001. A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition. J. Cell Biol. 155, 1265-1273
12. Deshaies, R.J., 1999. SCF and cullin/ring H2-based ubiquitin ligases. Annu. Rev. Cell Dev. Biol. 15, 435-467
13. Dou, Q.P., Li, B., 1999. Proteasome inhibitors as potential novel anticancer agents. Drug Resist. Updates 2, 215-223
14. Fakharzadeh, S.S., Trusko, S.P., George, D.L., 2001. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10, 1565-1569
15. Fang, S., Jensen, J.P., Ludwig, R.L., Vousden, K.H., Weissman, A.M., 2000. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275, 8945-8951
16. Geyer, R.K., Yu, Z.K., Maki, C.G., 2000, The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat. Cell Biol. 2, 569-573
17. Glotzer, M., Murray, A.W., Kirschner, M.W., 1991. Cyclin is degraded by the ubiquitin pathway, Nature 349, 132-138
18. Gmachl, M., Gieffers, C., Podtelejnikov, A.V., Mann, M., Peters, J.M., 2000. The RING-H2 finger protein APC11 and the E2 enzyme UBC4 are sufficient to ubiquitinate substrates of the anaphase-promoting complex. Proc. Natl. Acad. Sci. U.S.A. 97, 8973-8978
19. Gstaiger, M., Jordan, R., Lim, M., Catzavelos, C., Mestan, J., Slingerland, J., Krek, W., 2001. Skp2 is oncogenic and overexpressed in human cancers. Proc. Natl. Acad. Sci. U.S.A. 98, 5043-5048
20. Harper, J.W., Burton, J.L., Solomon, M.J., 2002, The anaphase-promoting complex: it's not just for mitosis any more. Genes Dev. 16, 2179-2206
21. Hata, A., Shi, Y., Massague, J., 1998, TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads. Mol. Med. Today 4, 257-262
22. Hatakeyama, S., Yada, M., Matsumoto, M., Ishida, N., Nakayama, K.I., 2001. U box proteins as a new family of ubiquitin-protein ligases. J. Biol. Chem. 276, 33111-33120
23. Haupt, Y., Maya, R., Kazaz, A., Oren, M., 1997. Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299
24. Hoege, C., Pfander, B., Moldovan, G.L., Pyrowolakis, G., Jentsch, S., 2002. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419, 135-141
25. Honda, R., Yasuda, H., 1999. Association of pl9(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18, 22-27
26. Huang, L., Kinnucan, E., Wang, G., Beaudenon, S., Howley, P.M., Huibregtse, J.M., Pavletich, N.P., 1999. Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. Science 286, 1321-1326
27. Jackson, M.W., Berberich, S.J., 2000. MdmX protects p53 from Mdm2-mediated degradation. Mol. Cell Biol. 20, 1001-1007
28. Jackson, P.K., Eldridge, A.G., 2002. The SCF ubiquitin ligase: an extended look. Mol. Cell 9, 923-925
29. Jackson, P.K., Eldridge, A.G., Freed, E., Furstenthal, L., Hsu, J.Y., Kaiser, B.K., Reimann, J.D., 2000. The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends Cell Biol. 10, 429-439
30. Jaspersen, S.L., Charles, J.F., Morgan, D.O., 1999. Inhibitory phosphorylation of the APC regulator Hctl is controlled by the kinase Cdc28 and the phosphatase Cdcl4. Curr. Biol. 9, 227-236
31. Jiang, F., Basavappa, R., 1999. Crystal structure of the cyclin-specific ubiquitin-conjugating enzyme from clam, E2-C, at 2.0 Å resolution. Biochemistry 38, 6471-6478
32. Kang, D., Chen, J., Wong, J., Fang, G., 2002. The checkpoint protein Chfr is a ligase that ubiquitinates Plkl and inhibits Cdc2 at the G2 to M transition. J. Cell Biol. 156, 249-259
33. Karin, M., Cao, Y., Greten, F.R., Li, Z.W., 2002. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2, 301-310
34. King, R.W., Glotzer, M., Kirschner, M.W., 1996. Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates. Mol. Biol. Cell 7, 1343-1357
35. Kipreos, E.T., Pagano, M., 2000. The F-box protein family, Genome Biol. 1, 3002.1-3002.7 (reviews)
36. Kotani, S., Tanaka, H., Yasuda, H., Todokoro, K., 1999. Regulation of APC activity by phosphorylation and regulatory factors. J. Cell Biol. 146, 791-800
37. Kotani, S., Tugendreich, S., Fujii, M., Jorgensen, P.M., Watanabe, N., Hoog, C., Hieter, P., Todokoro, K., 1998. PKA and MPF-activated polo-like kinase regulate anaphase-promoting complex activity and mitosis progression. Mol. Cell. 1, 371-380
38. Lai, Z., Ferry, K.V., Diamond, M.A., Wee, K.E., Kim, Y.B., Ma, J., Yang, T., Benfield, P.A., Copeland, R.A., Auger, K.R., 2001. Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization. J. Biol. Chem. 276, 31357-31367
39. Lake, M.W., Wuebbens, M.M., Rajagopalan, K.V., Schindelin, H., 2001. Mechanism of ubiquitin activation revealed by the structure of a bacterial MoeB-MoaD complex. Nature 414, 325-329
40. Leverson, J.D., Joazeiro, C.A., Page, A.M., Huang, H., Hieter, P., Hunter, T., 2000. The APC11 RING-H2 finger mediates E2-dependent ubiquitination. Mol. Biol. Cell 11, 2315-2325
41. Lin, Y., Hwang, W.C., Basavappa, R., 2002, Structural and functional analysis of the human mitotic-specific ubiquitin-conjugating enzyme, UbcH10. J. Biol. Chem. 277, 21913-21921
42. Martin, S.J., 2002. Destabilizing influences in apoptosis: sowing the seeds of IAP destruction. Cell 109, 793-796
43. Masuda, T.A., Inoue, H., Sonoda, H., Mine, S., Yoshikawa, Y., Nakayama, K., Nakayama, K., Mori, M., 2002. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res. 62, 3819-3825
44. Maxwell, P.H., Pugh, C.W., Ratcliffe, P.J., 2001. The pVHL-hlF-1 system. A key mediator of oxygen homeostasis. Adv. Exp. Med. Biol. 502, 365-376
45. Midgley, C.A., Desterro, J.M., Saville, M.K., Howard, S., Sparks, A., Hay, R.T., Lane, D.P., 2000. An N-terminal pl4ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene 19, 2312-2323
46. Momand, J., Jung, D., Wilczynski, S., Niland, J., 1998. The MDM2 gene amplification database. Nucleic Acids Res. 26, 3453-3459
47. Momand, J., Zambetti, G.P., Olson, D.C., George, D., Levine, A.J., 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245
48. Moraes, T.F., Edwards, R.A., McKenna, S., Pastushok, L., Xiao, W., Glover, J.N., Ellison, M.J., 2001. Crystal structure of the human ubiquitin conjugating enzyme complex, hMms2-hUbc13. Nat. Struct. Biol. 8, 669-673
49. Ohh, M., Kim, W.Y., Moslehi, J.J., Chen, Y., Chau, V., Read, M.A., Kaelin, Jr., W.G., 2002. An intact NEDD8 pathway is required for cullin-dependent ubiquitylation in mammalian cells. EMBO Rep. 3, 177-182
50. Oliner, J.D., Pietenpol, J.A., Thiagalingam, S., Gyuris, J., Kinzler, K.W., Vogelstein, B., 1993. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362, 857-860
51. Patra, D., Dunphy, W.G., 1998. Xe-p9, a Xenopus Sucl/Cks protein, is essential for the Cdc2-dependent phosphorylation of the anaphase-promoting complex at mitosis. Genes Dev. 12, 2549-2559
52. Peters, J.M., King, R.W., Hoog, C., Kirschner, M.W., 1996. Identification of BIME as a subunit of the anaphase-promoting complex. Science 274, 1199-1201
53. Pfleger, C.M., Kirschner, M.W., 2000. The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1. Genes Dev. 14, 655-665
54. Pickart, C.M., 2001. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503-533
55. Prinz, S., Hwang, E.S., Visintin, R., Amon, A., 1998. The regulation of Cdc20 proteolysis reveals a role for APC components Cdc23 and Cdc27 during S phase and early mitosis. Curr. Biol. 8, 750-760
56. Reimann, J.D., Freed, E., Hsu, J.Y., Kramer, E.R., Peters, J.M., Jackson, P.K., 2001. Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase-promoting complex. Cell 105, 645-655
57. Scheffner, M., Huibregtse, J.M., Vierstra, R.D., Howley, P.M., 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495-505
58. Scheffner, M., Wemess, B.A., Huibregtse, J.M., Levine, A.J., Howley, P.M., 1990, The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136
59. Scully, R., Livingston, D.M., 2000. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408, 429-432
60. Sekizawa, R., Ikeno, S., Nakamura, H., Naganawa, H., Matsui, S., Iinuma, H., Takeuchi, T., 2002. Panepophenanthrin, from a mushroom strain, a novel inhibitor of the ubiquitin-activating enzyme. J. Nat. Products 65, 1491-1493
61. Shah, J.V., Cleveland, D.W., 2000. Waiting for anaphase: Mad2 and the spindle assembly checkpoint. Cell 103, 997-1000
62. Sharp, D.A., Kratowicz, S.A., Sank, M.J., George, D.L., 1999. Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein. J. Biol. Chem. 274, 38189-38196
63. Shirayama, M., Zachariae, W., Ciosk, R., Nasmyth, K., 1998. The Polo-like kinase Cdc5p and the WD-repeat protein Cdc20p/fizzy are regulators and substrates of the anaphase promoting complex in Saccharomyces cerevisiae. EMBO J. 17, 1336-1349
64. Swinney, D.C., Xu, Y.Z., Scarafia, L.E., Lee, I., Mak, A.Y., Gan, Q.F., Ramesha, C.S., Mulkins, M.A., Dunn, J., So, O.Y., Biegel, T., Dinh, M., Volkel, P., Barnett, J., Dalrymple, S.A., Lee, S., Huber, M., 2002. A small molecule ubiquitination inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats. J. Biol. Chem. 277, 23573-23581
65. Tang, Z., Li, B., Bharadwaj, R., Zhu, H., Ozkan, E., Hakala, K., Deisenhofer, J., Yu, H., 2001. APC2 cullin protein and APC11 RING protein comprise the minimal ubiquitin ligase module of the anaphase-promoting complex. Mol. Biol. Cell 12, 3839-3851
66. Thut, C.J., Chen, J.L., Klemm, R., Tjian, R., 1995. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science 267, 100-104
67. Urano, T., Saito, T., Tsukui, T., Fujita, M., Hosoi, T., Muramatsu, M., Ouchi, Y., Inoue, S., 2002. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature 417, 871-875
68. VanDemark, A.P., Hofmann, R.M., Tsui, C., Pickart, C.M., Wolberger, C., 2001. Molecular insights into polyubiquitin chain assembly: crystal structure of the Mms2/Ubc13 heterodimer. Cell 105, 711-720
69. Verweij, J., de Vries, E.G.E., 2001. Clinical cancer research 2001: new agents and therapies. Drug Resist. Updates 4, 217-223
70. Worthylake, D.K., Prakash, S., Prakash, L., Hill, C.P., 1998. Crystal structure of the Saccharomyces cerevisiae ubiquitin-conjugating enzyme Rad6 at 2.6 Å resolution. J. Biol. Chem. 273, 6271-6276
71. Xirodimas, D., Saville, M.K., Edling, C., Lane, D.P., Lain, S., 2001. Different effects of pl4ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. Oncogene 20, 4972-4983
72. Xu, J., Attisano, L., 2000. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting. Smads to the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. U.S.A. 97, 4820-4825
73. Yamada, H., Kumada, K., Yanagida, M., 1997. Distinct subunit functions and cell cycle regulated phosphorylation of 20S APC/cyclosome required for anaphase in fission yeast. J. Cell Sci. 110, 1793-1804
74. Yang, Y., Fang, S., Jensen, J.P., Weissman, A.M., Ashwell, J.D., 2000. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288, 874-877
75. Zachariae, W., Nasmyth, K., 1999. Whose end is destruction: cell division and the anaphase-promoting complex. Genes Dev. 13, 2039-2058
76. Zachariae, W., Schwab, M., Nasmyth, K., Seufert, W., 1998. Control of cyclin ubiquitination by CDK-regulated binding of Hctl to the anaphase promoting complex. Science 282, 1721-1724
77. Zhang, Y., Chang, C., Gehling, D.J., Hemmati-Brivanlou, A., Derynck, R., 2001. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc. Natl. Acad. Sci. U.S.A. 98, 974-979
78. Zhang, Y., Xiong, Y., 2001. Control of p53 ubiquitination and nuclear export by MDM2 and ARF. Cell Growth Differ. 12, 175-186
79. Zheng, N., Schulman, B.A., Song, L., Miller, J.J., Jeffrey, P.D., Wang, P., Chu, C., Koepp, D.M., Elledge, S.J., Pagano, M., Conaway, R.C., Conaway, J.W., Harper, J.W., Pavletich, N.P., 2002. Structure of the Cu11-Rbx1-Skp1-F box Skp2 SCF ubiquitin ligase complex. Nature 416, 703-709
80. Zheng, N., Wang, P., Jeffrey, P.D., Pavletich, N.P., 2000. Structure of a c-Cb1-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102, 533-539
81. Zhu, H., Kavsak, P., Abdollah, S., Wrana, J.L., Thomsen, G.H., 1999. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400, 687-693